Efektivitas Program Meditasi Buddhis Terstruktur (Mindful Resilience After Stroke - MRAS) terhadap Regulasi Emosi dan Kualitas Hidup Pasien Pasca Stroke

Ratnasari Ratnasari

doi:10.61132/jbpab.v3i4.1468

Authors

Ratnasari Ratnasari Institut Nalanda

DOI:

https://doi.org/10.61132/jbpab.v3i4.1468

Keywords:

Buddhist Meditation, Emotion Regulation, Mindfulness, Neurorehabilitation, Quality of Life

Abstract

Impaired emotion regulation and decreased quality of life are common, yet often untreated, sequelae of stroke. Conventional rehabilitation primarily targets physical and cognitive recovery, leaving affective disturbances unaddressed. This study examined the efficacy of a structured Buddhist meditation program—Mindful Resilience After Stroke (MRAS)—for improving emotion regulation and quality of life in stroke survivors. Forty-two ischemic/hemorrhagic stroke patients (3–18 months post-onset) were consecutively recruited and randomly allocated to an intervention group (n = 21) receiving an 8-week MRAS protocol (1 × 60 min/week) or a control group (n = 21) receiving standard care only. Emotion regulation was assessed with the Difficulties in Emotion Regulation Scale-Short Form (DERS-SF) and quality of life with the Stroke-Specific Quality of Life Scale (SS-QOL). Between-group changes (Δ post-pre) were analyzed using independent t-tests or Mann–Whitney U tests (α = 0.05). The intervention group showed a significantly greater reduction in emotion-regulation difficulties than controls (ΔDERS-SF −18.4 ± 5.1 vs. −3.2 ± 4.3; p < 0.001; d = 1.62). Quality-of-life gains were also larger in the intervention group (ΔSS-QOL 35.7 ± 8.9 vs. 7.1 ± 6.5; p < 0.001; d = 1.89). The most improved sub-domains were emotional acceptance, emotional awareness, and impulse control (DERS-SF), as well as energy, mood, and social participation (SS-QOL). No intervention-related adverse events were reported. MRAS is an effective and safe adjunctive intervention to enhance emotion regulation and quality of life after stroke. Embedding mindfulness practices grounded in Buddhist tradition into stroke rehabilitation offers a holistic, culturally adaptable approach for neuropsychological services in Indonesia.

Downloads

Download data is not yet available.

References

Abd El-Hack, M. E., El-Saadony, M. T., & Alagawany, M. (2023). Antioxidant evaluation and computational prediction of prospective drug-like compounds from polyphenolic-rich extract of Hibiscus cannabinus L. seed as antidiabetic and neuroprotective targets. BMC Complementary Medicine and Therapies, 23(4), 4023. https://doi.org/10.1186/s12906-023-04023-7

Amin, S., et al. (2025). Aktivitas senyawa bioaktif brotowali (Tinospora crispa L.) sebagai agen antidiabetes: Kajian kimia medisinal dan molekuler docking. Jurnal Ners, 9(2), 2962–2968.

Amin, S., et al. (2025). Analisis in silico senyawa bioaktif kulit buah manggis (Garcinia mangostana L.) sebagai kandidat inhibitor enzim diabetes tipe 2. Journal of Innovative and Creativity, 240–245.

Amin, S., et al. (2025). Literature review: Pendekatan in silico potensi senyawa dalam daun kelor (Moringa oleifera L.) sebagai kandidat antidiabetes. Journal of Innovative and Creativity.

Amin, S., & Pitara, D. (2025). Potensi kombinasi senyawa bioaktif kumis kucing (Orthosiphon stamineus) dan daun yakon (Smallanthus sonchifolius) sebagai terapi diabetes mellitus: Studi in silico dan prediksi ADMET. Journal of Public Health Science (JoPHS), 2(1).

Amin, S., Muhtar, N. L. N., Kaamilah, D., & Yulianingsih, T. S. (2024). Studi in silico senyawa bioaktif daun salam (Syzygium polyanthum) sebagai antidiabetes melalui mekanisme inhibitor SGLT-2. Jurnal Ilmu Medis Indonesia, 4(1), 21–29. https://doi.org/10.35912/jimi.v4i1.4539

Berkes, F. (2017). Sacred Ecology: Traditional Ecological Knowledge and Resource Management (4th ed.). Routledge. https://doi.org/10.4324/9781315114644

Bumolo, N., et al. (2025). In silico study of the potential of Moringa oleifera secondary metabolites as α-glucosidase inhibitors. Indonesian Journal of Pharmaceutical Education (e-Journal), 5(1), 132–141.

El-Khatib, A. H., & Hassan, S. M. (2023). In vitro and in silico studies to explore potent antidiabetic inhibitors from the methanolic extract of the green microalga Chlorella vulgaris. BioMed Research International, 2023, 37561393. https://doi.org/10.1155/2023/37561393

Eltiga Angga Putra Sihombing, Dwi Yuliani, M.Si, Ph.D., & Dra. Windriyanti, M. (2020). Pelaksanaan program rehabilitasi sosial bagi gelandangan dan pengemis di Balai Rehabilitasi Sosial Gelandangan dan Pengemis di Pulau Jawa. Jurnal Ilmiah Rehabilitasi Sosial, 2(2).

Faturochman. (2017). Keadilan sosial: Suatu tinjauan psikologi. Buletin Psikologi, 2(2), 121. http://repository.upy.ac.id/1716/%0Ahttps://www.kemendagri.go.id/index.php/blog/27002-sebanyak-16056-pulau-bernama-indonesia-telah-

Gupta, V., & Jain, A. D. (2012). Diabetes mellitus: Exploring the challenges in the drug development process. Current Drug Targets, 13(8), 1322–1329. https://pubmed.ncbi.nlm.nih.gov/23125962/

Hilma, R., et al. (2020). Pengukuran total fenolik, flavonoid, aktivitas antioksidan dan antidiabetes ekstrak etil asetat daun katemas (Euphorbia heterophylla L.) secara in vitro dan in silico melalui inhibisi enzim α-glukosidase. Alchemy: Jurnal Penelitian Kimia, 16(2), 240–249.

Huang, L., Zhang, Q., & Wang, Z. (2024). Advancements and challenges in the research and development of antidiabetic medicines. Journal of Basic and Clinical Pharmacology, 15(1), 21–35.

International Diabetes Federation. (2024). IDF Diabetes Atlas (11th ed.). Brussels, Belgium: International Diabetes Federation. https://idf.org

Pangemanan, K., et al. (2022). Uji aktivitas antidiabetes daging buah alpukat mentega (Parsea americana) sebagai inhibitor enzim α-glucosidase secara in silico. Pharmacy Medical Journal, 5(2).

Rachmania, R. A., et al. (2015). Analisis in-silico senyawa diterpenoid lakton herba sambiloto (Andrographis paniculata Nees) pada reseptor α-glucosidase sebagai antidiabetes tipe II. Pharmacy, 12(2).

Sari, D. P., Hidayat, T., & Nurjanah, D. (2023). Phytochemical profiling and antidiabetic evaluation of Peperomia pellucida as a potential alpha-glucosidase inhibitor. Biodiversitas Journal of Biological Diversity, 24(10), 15819. https://doi.org/10.13057/biodiv/d241019

Siti Halimatus Sa’diyah, S., Amin, S., & Wibowo, R. (2025). Antidiabetic medicinal plants of Indonesia: Their in silico, in vitro, in vivo and clinical trial studies. Phytochemistry Reviews. Springer Nature. https://doi.org/10.1007/s11101-025-10173-y

Shofi, M. (2021). Uji in silico aktivitas sitotoksik dan toksisitas senyawa bioaktif biji trembesi (Samanea saman (Jacq.) Merr) sebagai kandidat obat diabetes mellitus. Jurnal Pharma Bhakti.

Susilawati, E., et al. (2023). Review of the case reports on metformin, sulfonylurea, and thiazolidinedione therapies in type 2 diabetes mellitus patients. Medical Sciences.

Zeb, A., Al-Ghamdi, A. A., & Ullah, F. (2023). Chemical characterisation, antidiabetic, antibacterial, and in silico studies for different extracts of Haloxylon stocksii. Molecules, 28(9), 3847. https://doi.org/10.3390/molecules28093847